Exoxemis, Inc., Little Rock, AR, USA
Review Article
Antiseptic Action of E-101 Solution, a Myeloperoxidase-Mediated Formulation, in the Presence of Whole Blood Compared to Conventional Wound Antiseptics and Biocides
Author(s): Gerald A. Denys*, Jessica L. Carpenter, Robert C. Allen and Jackson T. Stephens Jr
E-101 solution is a first-in-class myeloperoxidase containing antimicrobial solution developed for topical application. The active ingredients in E-101 solution
are two enzymes, porcine myeloperoxidase (pMPO) and glucose oxidase (GO) in an aqueous solution and activated by the addition of a glucose solution. Once
activated, the reactive species hydrogen peroxide, hypochlorous acid/hypochlorite (HOCl/OCl-), and singlet oxygen (1O2) are generated. We evaluated the effect
of whole human blood on the performance of E-101 solution compared to commercially available wound antiseptics and commonly used biocides. The wound
cleansers NeutroPhase, Microcyn, and Vashe with the active HOCl/OCl- component were tested according to the USP-51 effectiveness test in the presence of
0, 1, 2 and 5% blood. Comparative time-kill studies against chlorhexidine, povidone-iodine, sodium oxychlorosene were t.. Read More»
Journal of Antimicrobial Agents received 444 citations as per Google Scholar report